News | Heart Failure | December 16, 2021

First-Of-Its-Kind Medicare Advantage Plan Addresses Diabetics With Heart Failure

New York and Vermont plan is one of three plans in the country to offer free, level 3 cardiac rehab

First-Of-Its-Kind Medicare Advantage Plan Addresses Diabetics With Heart Failure. Getty images

Getty images


December 16, 2021 — MVP Health Care and The University of Vermont Health Network recently announced their joint Medicare Advantage Plan, called UVM Health Advantage, will offer older adults in Northern New York and Vermont support for their two biggest health concerns: heart disease and diabetes. The plan provides 3 months of free medically tailored meals for those diagnosed with congestive heart failure, up to 36 free rides to or from medical appointments, a digital blood pressure cuff and pulse oximeter, low-cost orthotics and diabetic shoes, and more. Members of UVM Health Advantage will also have access to MVP’s vast network of physicians across Vermont and New York.

“UVM Health Advantage delivers a completely new Medicare Advantage experience – one that’s simpler, easier to use, and designed with our members and their physicians,” said MVP Health Care’s president and Chief Executive Officer, Christopher Del Vecchio. “We’re proud to pioneer this vision in partnership with UVM Health Network, which offers bold options for fighting two wide-spread conditions that older adults are facing.”

According to the CDC, heart disease is the leading cause of death in New York and Vermont, which is why UVM Health Advantage is supporting older adults as they navigate their health journey against this condition. Cardiac rehab level 3, which is designed to maintain a healthier lifestyle through supervised exercise sessions and health education, is covered at no cost — one of only three insurance plans in the country to so. Additionally, studies have shown the link between good dental hygiene and cardiac care — which is why UVM Health Advantage also offers robust dental benefits to its members.

Diabetes was also a top concern among older adults in the region, as more than 1.7 million New Yorkers and more than 55,000 Vermonters have been diagnosed with the condition. UVM Health Advantage covers routine podiatry visits, provides a glucometer and related supplies, includes low-cost orthotics and diabetic shoes, and free gym memberships to support in living a healthier lifestyle.

“We know that heart disease and diabetes can be successfully managed if patients have the right tools and support they need,” said John R. Brumsted, M.D., president and CEO of The University of Vermont Health Network. “We are excited about our partnership with MVP to offer a plan that can help older adults in our region live healthier lives.”

For more information: www.uvmhealthadvantage.com


Related Content

Feature | Heart Failure | Kyle Hardner

Editor's Note: This is Part Three of a three-part series highlighting several of the presentations from the American ...

Home May 13, 2026
Home
News | Heart Failure

May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...

Home May 11, 2026
Home
Feature | Heart Failure | Kyle Hardner

Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the ...

Home May 04, 2026
Home
News | Heart Failure

April 21, 2026 — Nuwellis, Inc. has announced a software update to its Aquadex SmartFlow ultrafiltration platform. The ...

Home April 23, 2026
Home
News | Heart Failure

March 28, 2026 — Amgen announced today that Repatha (evolocumab), when added to statins or other low-density lipoprotein ...

Home April 06, 2026
Home
News | Heart Failure

March 24, 2026 — New research shows that small improvements to sleep, diet quality and physical activity, made in ...

Home March 25, 2026
Home
News | Heart Failure

March 16, 2026 — Cytokinetics has announced four presentations related to Myqorzo (aficamten) at the American College of ...

Home March 16, 2026
Home
Feature | Heart Failure | Rohit Sood, MD, PhD

Cardiovascular disease (CVD) is a serious global health burden that encompasses a broad group of diseases that affect ...

Home February 12, 2026
Home
News | Heart Failure

Feb. 3, 2026 — Bristol Myers Squibb has launched "Change the Target. Change What’s Possible," an educational campaign ...

Home February 03, 2026
Home
News | Heart Failure

Jan. 27, 2026 — A new national study reveals a stark disconnect between Americans’ desire for preventive cardiac ...

Home January 27, 2026
Home
Subscribe Now